These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
130 related items for PubMed ID: 7915918
1. [Epithelial cancer of the ovary: current data]. Ozols RF. Bull Cancer; 1993 Nov; 80(11):955-70. PubMed ID: 7915918 [Abstract] [Full Text] [Related]
2. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N, Parma G, Bocciolone L, Franchi D, Sideri M, Maggioni A. Forum (Genova); 2000 Nov; 10(4):323-32. PubMed ID: 11535983 [Abstract] [Full Text] [Related]
4. Chemotherapy of advanced ovarian cancer. Martoni A, Cacciari N, Angelelli B, Zamagni C, Pannuti F. Front Biosci; 1997 Mar 15; 2():g20-6. PubMed ID: 9159262 [Abstract] [Full Text] [Related]
5. Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer. German AGO Study Group Ovarian Cancer. Arbeitsgemeinschaft Gynäkologische Onkologie. du Bois A, Lück HJ, Meier W, Möbus V, Costa S, Richter B, Bauknecht T, Warm M, Schroeder W, Olbricht S, Nitz U, Jackisch C. Semin Oncol; 1997 Aug 15; 24(4 Suppl 11):S11-28-S11-33. PubMed ID: 9314296 [Abstract] [Full Text] [Related]
6. [Treatment of ovarian cancer]. Cianti C. Clin Ter; 2002 Aug 15; 153(2):135-44. PubMed ID: 12078339 [Abstract] [Full Text] [Related]
14. Efficacy and safety of the combination paclitaxel/carboplatin in patients with previously treated advanced ovarian carcinoma: a multicenter French Groupe des Investigateurs Nationaux pour l'Etude des Cancers Ovariens phase II study. Pujade-Lauraine E, Guastalla JP, Weber B, Curé H, Orfeuvre H, Mousseau M, Vincent P, Diéras V, Tubiana-Mathieu N, Jacquin JP, Mignot L, Leduc B, Paraïso D, Viens P. Semin Oncol; 1997 Oct 15; 24(5 Suppl 15):S15-30-S15-35. PubMed ID: 9346219 [Abstract] [Full Text] [Related]
15. Carboplatin/paclitaxel versus cisplatin/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynäkologische Onkologie Ovarian Cancer Study Group. du Bois A, Lück HJ, Meier W, Möbus V, Costa S, Richter B, Warm M, Bauknecht T, Schröder W, Olbricht S, Nitz U, Jackisch C. Semin Oncol; 1997 Oct 15; 24(5 Suppl 15):S15-44-S15-52. PubMed ID: 9346222 [Abstract] [Full Text] [Related]
18. Paclitaxel with carboplatin versus paclitaxel with carboplatin alternating with cisplatin as first-line chemotherapy in advanced epithelial ovarian cancer: preliminary results of a Hellenic Cooperative Oncology Group study. Skarlos DV, Aravantinos G, Kosmidis P, Athanassiadis A, Stathopoulos GP, Pavlidis N, Bafaloukos D, Karphathios S, Papakostas P, Bamia C, Fountzilas G. Semin Oncol; 1997 Oct 15; 24(5 Suppl 15):S15-57-S15-61. PubMed ID: 9346224 [Abstract] [Full Text] [Related]
19. Activity of chemotherapy in mucinous epithelial ovarian cancer: a retrospective study. Pisano C, Greggi S, Tambaro R, Losito S, Iodice F, Di Maio M, Ferrari E, Falanga M, Formato R, Iaffaioli VR, Pignata S. Anticancer Res; 2005 Oct 15; 25(5):3501-5. PubMed ID: 16101169 [Abstract] [Full Text] [Related]